Mid-Course Weight Loss and a Loose Mask: Treat or Hold?
Mr. D, 61, has T4N2 oropharyngeal carcinoma and is at fraction 18 of 35 (70 Gy) with concurrent cisplatin. He has lost 8 kg in three weeks (84 to 76 kg) and his mask is visibly loose. Today's CBCT shows a 5 mm inferior shift of the mandible and 4 mm anterior shift of C2 relative to the planning CT; a quick estimate suggests PTV coverage on today's scan is about 92%. He has grade 2 mucositis, has already missed 3 days, and drove 90 minutes for this appointment. The treating radiation oncologist is at a conference; the covering physician is at another hospital and reachable by phone.
1. Should Mr. D be treated today? What information drives the decision?
Read the worked answer
Do not treat reflexively, and do not send him home reflexively. The decision rests on three questions:
- Is the shift systematic and anatomically real, or is it setup error? Re-image after repositioning. A 5 mm mandibular and 4 mm C2 shift with visible weight loss suggests anatomy change, not random error, but a repeat CBCT with a better-fitting mask or a bite block can distinguish them.
- What is the actual dosimetric cost? A therapist's visual estimate of 92% coverage is a red flag, not a number. The covering RO needs a real answer: either a same-day CT and rapid re-plan, or a documented decision that a single fraction at the current position is acceptable.
- What is the cost of another missed day? Three missed days already, with a 35-fraction concurrent chemoradiation course - cumulative gaps reduce local control. Avoiding a treat is not free.
Call the covering RO with the images, the estimated shift, and the missed-day history, and let the physician make the call. Treating unilaterally or holding unilaterally are both wrong.
2. If the decision is to re-plan, what must be done and by whom?
Read the worked answer
A re-plan after 8 kg of weight loss and 5 mm mandibular shift requires more than a new mask:
- New simulation CT in the treatment position with the same immobilization and, ideally, the same contrast/IV protocol and bladder/bowel instructions. Consider a new mask - the old one is no longer immobilizing.
- Fusion to the original planning CT and re-contouring of target volumes and organs at risk (parotids, mandible, constrictors, spinal cord). GTV/CTV may need re-delineation, not just copying forward.
- Physician approval of the new volumes and a dosimetric comparison of old vs. new plan: cumulative dose to cord and brainstem from the 17 delivered fractions must be accounted for when the new plan is optimized. This is a composite-plan calculation, not a fresh start.
- Repeat patient-specific QA if the technique or plan changes materially.
- Documentation of the reason, the dates, and the physician sign-off, and communication to the chemotherapy team about the weight loss and nutrition.
Dosimetry and physics execute, but the covering RO approves volumes, the composite dose, and the treatment break.
3. What should be communicated to Mr. D today, and what follow-up prevents this from recurring?
Read the worked answer
Tell him plainly: his weight loss has changed his anatomy enough that today's scan does not match his plan, and continuing without checking risks both missing tumor and overdosing normal tissue. Explain what happens next and when (re-scan timing, expected delay), and be explicit that the missed days and the 90-minute drive are being weighed - he needs to know the team is not casually adding delay. Ask about intake, swallowing, pain, and whether he has transportation or lodging options for a shorter drive during the re-plan week.
Prevention: weekly weight and mask-fit checks with a documented threshold for re-simulation (e.g., >5% weight loss or a visibly loose mask), early dietitian and speech/swallow involvement, and a flag in the schedule for on-treatment visit review. Note the weight trend in the chart so the next therapist sees it before the mask is loose.